Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03680911 · ClinicalTrials.gov registry record · Phase 3
NAC for Head Trauma-induced Anosmia
A Phase 3 study, sponsored by University of Miami.
- Terminated
- Registry status
- Phase 3
- Development phase
- 7
- Enrollment target
NCT03680911 is a Phase 3 study that was terminated before completion, run by University of Miami. The registered enrollment target is 7 participants.
The verdict
NCT03680911, a Phase 3 study, was terminated before completion, sponsored by University of Miami.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 7 participants
- Enrollment target
Study Summary
This study will compare administration of N-Acetyl Cysteine (NAC) versus placebo for the treatment of olfactory loss due to head injury. The hypothesis is that treatment with NAC acutely after head injury will result in improved olfactory function
Interventions
- DRUG Placebo oral capsule
- DRUG N Acetyl Cysteine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2018-10-12 |
| Est. Completion | 2020-01-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03680911
The ClinicalTrials.gov registry entry for NCT03680911 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo oral capsule is the first listed.
NCT03680911 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03680911 about?
NCT03680911 is a clinical study titled "NAC for Head Trauma-induced Anosmia". This study will compare administration of N-Acetyl Cysteine (NAC) versus placebo for the treatment of olfactory loss due to head injury. The hypothesis is that treatment with NAC acutely after head injury will result in improved olfactory function
What is the current status of trial NCT03680911?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 7 participants. The study started on 2018-10-12. Estimated completion is 2020-01-07.
What interventions are being tested in trial NCT03680911?
The interventions under investigation include: Placebo oral capsule (DRUG), N Acetyl Cysteine (DRUG).
Who is sponsoring clinical trial NCT03680911?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.